High-content imaging analysis of the knockdown effects of validated siRNAs and antisense oligonucleotides.
about
Applications of high content screening in life science researchCharacterization and preclinical development of LY2603618: a selective and potent Chk1 inhibitor.Phenotypic fingerprinting of small molecule cell cycle kinase inhibitors for drug discovery.A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cells.An overview of cell phenotypes in HCS: limitations and advantages.LY2603618, a selective CHK1 inhibitor, enhances the anti-tumor effect of gemcitabine in xenograft tumor models.
P2860
High-content imaging analysis of the knockdown effects of validated siRNAs and antisense oligonucleotides.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
High-content imaging analysis ...... nd antisense oligonucleotides.
@ast
High-content imaging analysis ...... nd antisense oligonucleotides.
@en
type
label
High-content imaging analysis ...... nd antisense oligonucleotides.
@ast
High-content imaging analysis ...... nd antisense oligonucleotides.
@en
prefLabel
High-content imaging analysis ...... nd antisense oligonucleotides.
@ast
High-content imaging analysis ...... nd antisense oligonucleotides.
@en
P2093
P2860
P356
P1476
High-content imaging analysis ...... nd antisense oligonucleotides.
@en
P2093
Eric Marcusson
Erich Koller
Jeff Hodson
Jonathan Low
Kerry Blanchard
Michele Dowless
Scott Davis
Shuguang Huang
Thomas Vincent
Wayne Blosser
P2860
P304
P356
10.1177/1087057107302675
P577
2007-05-21T00:00:00Z